The University of Southampton
University of Southampton Institutional Repository

Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2

Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2

Evidence-based health care decision making requires comparison of all relevant competing interventions. In the absence of randomized controlled trials involving a direct comparison of all treatments of interest, indirect treatment comparisons and network meta-analysis provide useful evidence for judiciously selecting the best treatment(s). Mixed treatment comparisons, a special case of network meta-analysis, combine direct evidence and indirect evidence for particular pairwise comparisons, thereby synthesizing a greater share of the available evidence than traditional meta-analysis. This report from the International Society for Pharmacoeconomics and Outcomes Research Indirect Treatment Comparisons Good Research Practices Task Force provides guidance on technical aspects of conducting network meta-analyses (our use of this term includes most methods that involve meta-analysis in the context of a network of evidence). We start with a discussion of strategies for developing networks of evidence. Next we briefly review assumptions of network meta-analysis. Then we focus on the statistical analysis of the data: objectives, models (fixed-effects and random-effects), frequentist versus Bayesian approaches, and model validation. A checklist highlights key components of network meta-analysis, and substantial examples illustrate indirect treatment comparisons (both frequentist and Bayesian approaches) and network meta-analysis. A further section discusses eight key areas for future research.

Advisory Committees/standards, Delivery of Health Care/standards, Economics, Pharmaceutical/standards, Humans, Meta-Analysis as Topic, Outcome Assessment, Health Care/standards, Practice Guidelines as Topic/standards, Randomized Controlled Trials as Topic/methods, Research Design/standards, Research Report/standards, Treatment Outcome
1098-3015
429-437
Hoaglin, David C
9ce4700f-f892-4166-8b46-447cd97088d8
Hawkins, Neil
1aa8112d-606d-4176-b306-9c22158c556d
Jansen, Jeroen P
127db34b-d04b-4249-bcc1-083a0ee0b976
Scott, David A
19b5fd34-9974-4ae4-8be0-27a693639e20
Itzler, Robbin
5f47c985-b503-46c8-bdfe-2d5d0898b0c0
Cappelleri, Joseph C
c8e41994-ea43-47d8-8c5c-c66b41e6d4fa
Boersma, Cornelis
3e426bcf-c8cd-414e-8f03-6dc1bc93a88f
Thompson, David
2c60eb1e-bdb8-4501-a2bf-e01780cc31be
Larholt, Kay M
0139dd34-59eb-4a43-935f-a9698ebf49fb
Diaz, Mireya
10a13062-1ce0-444b-ad13-b2925fbf096a
Barrett, Annabel
2b44435c-7350-4b2d-8b3a-a39d6536e8a2
Hoaglin, David C
9ce4700f-f892-4166-8b46-447cd97088d8
Hawkins, Neil
1aa8112d-606d-4176-b306-9c22158c556d
Jansen, Jeroen P
127db34b-d04b-4249-bcc1-083a0ee0b976
Scott, David A
19b5fd34-9974-4ae4-8be0-27a693639e20
Itzler, Robbin
5f47c985-b503-46c8-bdfe-2d5d0898b0c0
Cappelleri, Joseph C
c8e41994-ea43-47d8-8c5c-c66b41e6d4fa
Boersma, Cornelis
3e426bcf-c8cd-414e-8f03-6dc1bc93a88f
Thompson, David
2c60eb1e-bdb8-4501-a2bf-e01780cc31be
Larholt, Kay M
0139dd34-59eb-4a43-935f-a9698ebf49fb
Diaz, Mireya
10a13062-1ce0-444b-ad13-b2925fbf096a
Barrett, Annabel
2b44435c-7350-4b2d-8b3a-a39d6536e8a2

Hoaglin, David C, Hawkins, Neil, Jansen, Jeroen P, Scott, David A, Itzler, Robbin, Cappelleri, Joseph C, Boersma, Cornelis, Thompson, David, Larholt, Kay M, Diaz, Mireya and Barrett, Annabel (2011) Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value in Health, 14 (4), 429-437. (doi:10.1016/j.jval.2011.01.011).

Record type: Article

Abstract

Evidence-based health care decision making requires comparison of all relevant competing interventions. In the absence of randomized controlled trials involving a direct comparison of all treatments of interest, indirect treatment comparisons and network meta-analysis provide useful evidence for judiciously selecting the best treatment(s). Mixed treatment comparisons, a special case of network meta-analysis, combine direct evidence and indirect evidence for particular pairwise comparisons, thereby synthesizing a greater share of the available evidence than traditional meta-analysis. This report from the International Society for Pharmacoeconomics and Outcomes Research Indirect Treatment Comparisons Good Research Practices Task Force provides guidance on technical aspects of conducting network meta-analyses (our use of this term includes most methods that involve meta-analysis in the context of a network of evidence). We start with a discussion of strategies for developing networks of evidence. Next we briefly review assumptions of network meta-analysis. Then we focus on the statistical analysis of the data: objectives, models (fixed-effects and random-effects), frequentist versus Bayesian approaches, and model validation. A checklist highlights key components of network meta-analysis, and substantial examples illustrate indirect treatment comparisons (both frequentist and Bayesian approaches) and network meta-analysis. A further section discusses eight key areas for future research.

This record has no associated files available for download.

More information

Published date: June 2011
Keywords: Advisory Committees/standards, Delivery of Health Care/standards, Economics, Pharmaceutical/standards, Humans, Meta-Analysis as Topic, Outcome Assessment, Health Care/standards, Practice Guidelines as Topic/standards, Randomized Controlled Trials as Topic/methods, Research Design/standards, Research Report/standards, Treatment Outcome

Identifiers

Local EPrints ID: 441409
URI: http://eprints.soton.ac.uk/id/eprint/441409
ISSN: 1098-3015
PURE UUID: 66f5b36a-8268-497b-8a62-8b9dc5c71753
ORCID for David A Scott: ORCID iD orcid.org/0000-0001-6475-8046

Catalogue record

Date deposited: 11 Jun 2020 16:39
Last modified: 17 Mar 2024 04:02

Export record

Altmetrics

Contributors

Author: David C Hoaglin
Author: Neil Hawkins
Author: Jeroen P Jansen
Author: David A Scott ORCID iD
Author: Robbin Itzler
Author: Joseph C Cappelleri
Author: Cornelis Boersma
Author: David Thompson
Author: Kay M Larholt
Author: Mireya Diaz
Author: Annabel Barrett

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×